Bethesda Hospital, Tomohon, North Sulawasi, Indonesia Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2005
NCT01594931
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

artesunate (1 trial)

pyronaridine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 2)

Malaria, Falciparum (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2